Acción 688366 SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO., LTD.
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate

Otros idiomas Shanghai Haohai Biological Technology Co., Ltd. Shanghai S.E.

Acciones

688366

CNE100003NX4

Precio de cierre Shanghai S.E.
Otros sitios de cotización
 00:00:00 20/05/2024 		Varia. Cinco días. Varia. 1 de enero.
92,45 CNY +0,84 % Gráfico intradía de Shanghai Haohai Biological Technology Co., Ltd. -0,05 % -14,63 %
29/04 Shanghai Haohai Biological Technology Co. Ltd. presenta los resultados del primer trimestre finalizado el 31 de marzo de 2024 CI
11/03 Los beneficios de Shanghai Haohai en 2023 aumentan gracias a unos mayores ingresos; las acciones suben un 5 MT

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!
Inscripción 100% Gratuita
Shanghai Haohai Biological Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
Shanghai Haohai's 2023 Profit Rises on Higher Revenue; Shares Rise 5%
Shanghai Haohai Biological Technology Co., Ltd. Proposes Final Dividend for the Year Ended December 31, 2023, Payable on July 19, 2024
Shanghai Haohai Biological Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
Shanghai Haohai Biological Forecasts Up to 138% Boost in 2023 Profit
Shanghai Haohai Biological Technology Co., Ltd. Provides Preliminary Unaudited Consolidated Group Earnings Guidance for the Year Ended 31 December 2023
Tranche Update on Shanghai Haohai Biological Technology Co., Ltd.'s Equity Buyback Plan announced on September 27, 2023.
Shanghai Haohai Biological Technology Co., Ltd. Announces Resignation of Guo Yongqing as Independent Non-Executive Director, Chairman of Audit Committee, Member of Remuneration and Appraisal Committee and Member of Nomination Committee
Haohai Biological Technology's Q3 Profit Rises 34%; Hong Kong Shares Jump 5%
Shanghai Haohai Biological Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
Tranche Update on Shanghai Haohai Biological Technology Co., Ltd.'s Equity Buyback Plan announced on September 27, 2023.
Shanghai Haohai Biological Technology Co., Ltd. commences an Equity Buyback Plan for 1,538,461 shares, representing 0.9% for CNY 200 million, under the auhtorization approved on September 15, 2023.
Shanghai Haohai Biological Technology to See Rise in January-September Profit
Shanghai Haohai Biological Technology Co., Ltd. Provides Unaudited Consolidated Financial Guidance for the Nine Months Ended 30 September 2023
Shanghai Haohai Biological Technology's Profit Surges 188.9% in H1; Shares Up 3%
Shanghai Haohai Biological Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
Shanghai Haohai Biological Technology Co., Ltd. authorizes a Buyback Plan.
Shanghai Haohai Biological to Buy Remaining Stake in Medical Aesthetics, Cosmetology Business
Shanghai Haohai Biological Technology Co., Ltd. entered into the equity transfer agreement to acquire 36.3636% stake in OHMK Medical Technology Co., Ltd. from Tianjin Huacan Enterprise Management Consulting Partnership, Shanghai Ermei Enterprise Management Consulting Partnership, Yuan Yibing, Lian Songyong and Chen Guangfei for approximately CNY 150 million.
Shanghai Haohai Biological Technology’s H1 Profit to See Up to 210% Boost
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción 6826
  4. Acción 688366
  5. Noticias Shanghai Haohai Biological Technology Co., Ltd.
  6. Otros idiomas
-40% Oferta por Tiempo Limitado: Nuestras suscripciones le guían hacia las mejores inversiones del mañana.
APROVÉCHELO AHORA